These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 24523438)

  • 61. Histological inflammatory cell infiltration is associated with the number of lymph nodes retrieved in colorectal cancer.
    Kim YW; Jan KM; Jung DH; Cho MY; Kim NK
    Anticancer Res; 2013 Nov; 33(11):5143-50. PubMed ID: 24222162
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.
    Majid U; Bergsland CH; Sveen A; Bruun J; Eilertsen IA; Bækkevold ES; Nesbakken A; Yaqub S; Jahnsen FL; Lothe RA
    Cell Oncol (Dordr); 2024 Aug; 47(4):1267-1276. PubMed ID: 38407700
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
    Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
    Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P; Koch M; Nummer D; Palm S; Galindo L; Autenrieth D; Rahbari N; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Beckhove P; Weitz J
    Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
    Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
    Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.
    Ohta M; Tanaka F; Yamaguchi H; Sadanaga N; Inoue H; Mori M
    Int J Oncol; 2005 Jan; 26(1):41-7. PubMed ID: 15586223
    [TBL] [Abstract][Full Text] [Related]  

  • 67. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
    Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
    Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.
    Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Mantovani A; Marchesi F
    Int Rev Immunol; 2015 Mar; 34(2):123-33. PubMed ID: 25901857
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Surface profiles of live colorectal cancer cells and tumor infiltrating lymphocytes from surgical samples correspond to prognostic categories.
    Zhou J; Belov L; Chapuis P; Chan C; Armstrong N; Kaufman KL; Solomon MJ; Clarke SJ; Christopherson RI
    J Immunol Methods; 2015 Jan; 416():59-68. PubMed ID: 25445327
    [TBL] [Abstract][Full Text] [Related]  

  • 71. T cell subsets and colorectal cancer: discerning the good from the bad.
    Scurr M; Gallimore A; Godkin A
    Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
    Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
    Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Interplay Between Neutrophils and CD8
    Governa V; Trella E; Mele V; Tornillo L; Amicarella F; Cremonesi E; Muraro MG; Xu H; Droeser R; Däster SR; Bolli M; Rosso R; Oertli D; Eppenberger-Castori S; Terracciano LM; Iezzi G; Spagnoli GC
    Clin Cancer Res; 2017 Jul; 23(14):3847-3858. PubMed ID: 28108544
    [No Abstract]   [Full Text] [Related]  

  • 74. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.
    Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M
    J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.
    Kim Y; Wen X; Bae JM; Kim JH; Cho NY; Kang GH
    Histopathology; 2018 Oct; 73(4):663-671. PubMed ID: 29906313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma.
    Fukushima G; Sato E; Udo R; Tago T; Kasahara K; Mazaki J; Iwasaki K; Enomoto M; Ishizaki T; Nagakawa Y
    Anticancer Res; 2024 Sep; 44(9):3899-3906. PubMed ID: 39197911
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer.
    Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K; Hirakawa K; Ohira M
    PLoS One; 2021; 16(7):e0255049. PubMed ID: 34293030
    [TBL] [Abstract][Full Text] [Related]  

  • 78. T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.
    Leivonen SK; Pollari M; Brück O; Pellinen T; Autio M; Karjalainen-Lindsberg ML; Mannisto S; Kellokumpu-Lehtinen PL; Kallioniemi O; Mustjoki S; Leppä S
    Haematologica; 2019 Feb; 104(2):338-346. PubMed ID: 30237271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Emerging immunologic biomarkers: setting the (TNM-immune) stage.
    Taube JM
    Clin Cancer Res; 2014 Apr; 20(8):2023-5. PubMed ID: 24634379
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.
    Berntsson J; Svensson MC; Leandersson K; Nodin B; Micke P; Larsson AH; Eberhard J; Jirström K
    Int J Cancer; 2017 Oct; 141(8):1654-1666. PubMed ID: 28677162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.